Research News for April 13, 2022
advertisement
- The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus
- Shared gene expression signatures in type 1 diabetics treated with IL-2 and COVID-19 patients
- Esteemed Harvard Researcher Heads to Vertex to Curate Diabetes Portfolio
- Could AI Tool Identify Type 1 Diabetes Earlier in Childhood?
- Development of a rapid neutralization assay for the detection of neutralizing antibodies against coxsackievirus B1
- Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens
- Activation of T cell checkpoint pathways during β-cell antigen presentation by engineered dendritic cells promotes protection from type 1 diabetes
- Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes
- Cgmquantify: Python and R Software Packages for Comprehensive Analysis of Interstitial Glucose and Glycemic Variability from Continuous Glucose Monitor Data
- Analysis of Half a Billion Datapoints Across Ten Machine-Learning Algorithms Identifies Key Elements Associated With Insulin Transcription in Human Pancreatic Islet Cells (Full text HTML, PDF)
- β-cell mitochondria in diabetes mellitus: a missing puzzle piece in the generation of hPSC-derived pancreatic β-cells?
- Novel method utilizing bisulfite conversion with dual amplification-refractory mutation system polymerase chain reaction to detect circulating pancreatic β-cell cfDNA
- The Potential of Current Noninvasive Wearable Technology for the Monitoring of Physiological Signals in the Management of Type 1 Diabetes: Literature Survey
- A randomized, single ascending dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel insulin dimer
